Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)

0
68
Beef E. coli Outbreak investigation



Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to customer level. This recall was prompted as a result of detection of trace quantities of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a potential procedure impurity or contaminant in an active pharmaceutical ingredient, made by Hetero Labs Limited, Unit — I (API maker ).



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here